Medical Complications of Injection Drug Use — Part II
NEJM Evidence · 2023
DOI: 10.1056/evidra2300019 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift NEJM Evidence, 2023. Verfasst von Katherine M Rich und 1 weiteren Autor:innen. Beteiligte Einrichtung: Harvard Medical School, Boston. Hauptthemen laut MEDLINE: Substance Abuse, Intravenous, Epidemics. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 85 Literaturangaben.
Abstract (Originalsprache)
Medical Complications of Injection Drug Use - Part IIDuring the past 2 decades, the risk of death, as well as the prevalence of hospitalizations in the United States, has increased substantially among people who inject drugs, mainly because of the opioid epidemic. In Part Two of this two-part review, the authors review complications observed in people who inject drugs and strategies to reduce harm.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Harvard Medical School, Boston.
- Division of Infectious Diseases, Brigham and Women's Hospital, Boston.
Zitieren
APA
Rich, K. M., & Solomon, D. A. (2023). Medical Complications of Injection Drug Use — Part II. NEJM Evidence. https://doi.org/10.1056/evidra2300019
Vancouver
Rich KM, Solomon DA. Medical Complications of Injection Drug Use — Part II. NEJM Evidence. 2023. doi:10.1056/evidra2300019
BibTeX
@article{Rich2023,
author = {Rich, Katherine M and Solomon, Daniel A},
title = {Medical Complications of Injection Drug Use — Part II},
journal = {NEJM Evidence},
year = {2023},
doi = {10.1056/evidra2300019}
}
EUVIMED